The New York Times @nytimes
Monkeypox is finally showing signs of retreat in the U.S. But there are new concerns about the Biden administration’s plan to distribute fractional doses of the vaccine after a study suggested it would not be enough to prevent infection or severe symptoms. https://t.co/e5p7lkSWYw — PolitiTweet.org